Masahide Mizobuchi

6PUBLICATIONS
8CO-AUTHORS
Respiratory diseasesChemical thermodynamics and energeticsCardiology (incl. cardiovascular diseases)Counselling, wellbeing and community servicesToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 06, 2025
Phosphate binder pill burden and cardiovascular events in patients undergoing hemodialysis.

Kiryu Yoshida, Tomohiro Saito, Tadashi Kato

|Jul 18, 2023
Effects of evocalcet on parathyroid calcium-sensing receptor and vitamin D receptor expression in uremic rats.

Tomohiro Saito, Masahide Mizobuchi, Mariko Sakai

|Jun 14, 2023
Long-Term Effect of Denosumab on Bone Disease in Patients with CKD.

Ken Iseri, Masahide Mizobuchi, Renaud Winzenrieth

|Jan 06, 2021
Lower soluble Klotho levels in the pretransplant period are associated with an increased risk of renal function decline in renal transplant patients.

Yasuto Shikida, Masahide Mizobuchi, Osamu Yoshitake

|Nov 10, 2018
Secondary Hyperparathyroidism: Pathogenesis and Latest Treatment.

Masahide Mizobuchi, Hiroaki Ogata, Fumihiko Koiwa

|Aug 24, 2017
RAS Inhibitor Is Not Associated With Cardiovascular Benefits in Patients Undergoing Hemodialysis in Japan.

Masahide Mizobuchi, Hiroaki Ogata, Yoshihiro Onishi

Pageof 1

Frequent Collaborators

3 joint publications

Hiroaki Ogata

2 joint publications

Fumihiko Koiwa

2 joint publications

Tomohiro Saitou

1 joint publications

Shingo Fukuma